Tissue engineering applications in breast cancer

References

• Jazayeri SB, Saadat S, Ramezani R, et al. Incidence of primary breast cancer in Iran: ten-year national cancer registry data report. Cancer Epidemiol. 2015;39(4):519–527.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–E386.
   PubMed Web of Science ®Google Scholar
• Akbari ME, Akbari A, Nafissi N, et al. Recurrence and survival effect in breast conserving surgery: what are the predictive and/or prognostic factors? Iran J Cancer Prev. 2011;4(2):49–54.
   Google Scholar
• Barranger E, Antomarchi J, Chamorey E, et al. Effect of neoadjuvant chemotherapy on the surgical treatment of patients with locally advanced breast cancer requiring initial mastectomy. Clinical Breast Cancer. 2015;15(5):e231–e235.
   PubMed Web of Science ®Google Scholar
• Viola J, Lal B, Grad O. The emergence of tissue engineering as a research field. Arlington (VA): National Science Foundation; 2003. p. 2–11.
   Google Scholar
• Chang TT, Hughes-Fulford M. Monolayer and spheroid culture of human liver hepatocellular carcinoma cell line cells demonstrate distinct global gene expression patterns and functional phenotypes. Tissue Eng A. 2009;15(3):559–567.
   PubMed Web of Science ®Google Scholar
• Hutmacher DW, Horch RE, Loessner D, et al. Translating tissue engineering technology platforms into cancer research. J Cell Mol Med. 2009;13(8a):1417–1427.
   PubMed Web of Science ®Google Scholar
• Alemany-Ribes M, García-Díaz M, Busom M, et al. Toward a 3D cellular model for studying in vitro the outcome of photodynamic treatments: accounting for the effects of tissue complexity. Tissue Eng A. 2013;19(15–16):1665–1674.
   PubMed Web of Science ®Google Scholar
• Friedrich J, Seidel C, Ebner R, et al. Spheroid-based drug screen: considerations and practical approach. Nat Protoc. 2009;4(3):309–324.
   PubMed Web of Science ®Google Scholar
• Gimble JM, Katz AJ, Bunnell BA. Adipose-derived stem cells for regenerative medicine. Circ Res. 2007;100(9):1249–1260.
   PubMed Web of Science ®Google Scholar
• Krumboeck A, Giovanoli P, Plock JA. Fat grafting and stem cell enhanced fat grafting to the breast under oncological aspects – recommendations for patient selection. Breast. 2013;22(5):579–584.
   PubMed Web of Science ®Google Scholar
• Wu H, Zhou T, Tian L, et al. Self-assembling RADA16-I peptide hydrogel scaffold loaded with tamoxifen for breast reconstruction. BioMed Res Int. 2017;2017:1–10.
   Web of Science ®Google Scholar
• Schusterman MA, Rehnke RD, Clarke JM, et al. Breast reconstruction using a 3-dimensional absorbable mesh scaffold and autologous fat grafting: a composite strategy using tissue engineering principles. Plast Reconstr Surg Glob Open. 2019;7:8.
   Google Scholar
• Baldwin A, Uy L, Frank-Kamenetskii A, et al. The in vivo biocompatibility of novel tannic acid-collagen type I injectable bead scaffold material for breast reconstruction post-lumpectomy. J Biomater Appl. 2020;34(9):1315–1329.
   PubMed Web of Science ®Google Scholar
• Lequeux C, Oni G, Wong C, et al. Subcutaneous fat tissue engineering using autologous adipose-derived stem cells seeded onto a collagen scaffold. Plast Reconstr Surg. 2012;130(6):1208–1217.
   PubMed Web of Science ®Google Scholar
• Rijal G, Li W. 3D scaffolds in breast cancer research. Biomaterials. 2016;81:135–156.
   PubMed Web of Science ®Google Scholar
• Angeloni V, Contessi N, De Marco C, et al. Polyurethane foam scaffold as in vitro model for breast cancer bone metastasis. Acta Biomater. 2017;63:306–316.
   PubMed Web of Science ®Google Scholar
• Kar S, Molla MS, Katti DR, et al. Tissue‐engineered nanoclay‐based 3D in vitro breast cancer model for studying breast cancer metastasis to bone. J Tissue Eng Regen Med. 2019;13(2):119–130.
   PubMed Web of Science ®Google Scholar
• Dunne LW, Huang Z, Meng W, et al. Human decellularized adipose tissue scaffold as a model for breast cancer cell growth and drug treatments. Biomaterials. 2014;35(18):4940–4949.
   PubMed Web of Science ®Google Scholar
• Sahoo SK, Panda AK, Labhasetwar V. Characterization of porous PLGA/PLA microparticles as a scaffold for three dimensional growth of breast cancer cells. Biomacromolecules. 2005;6(2):1132–1139.
   PubMed Web of Science ®Google Scholar
• Wang X, Sun L, Maffini MV, et al. A complex 3D human tissue culture system based on mammary stromal cells and silk scaffolds for modeling breast morphogenesis and function. Biomaterials. 2010;31(14):3920–3929.
   PubMed Web of Science ®Google Scholar
• Janani G, Pillai MM, Selvakumar R, et al. An in vitro 3D model using collagen coated gelatin nanofibers for studying breast cancer metastasis. Biofabrication. 2017;9(1):15016.
   Web of Science ®Google Scholar
• Soman P, Kelber JA, Lee JW, et al. Cancer cell migration within 3D layer-by-layer microfabricated photocrosslinked PEG scaffolds with tunable stiffness. Biomaterials. 2012;33(29):7064–7070.
   PubMed Web of Science ®Google Scholar
• Pathi SP, Lin DD, Dorvee JR, et al. Hydroxyapatite nanoparticle-containing scaffolds for the study of breast cancer bone metastasis. Biomaterials. 2011;32(22):5112–5122.
   PubMed Web of Science ®Google Scholar
• Sims-Mourtada J, Niamat RA, Samuel S, et al. Enrichment of breast cancer stem-like cells by growth on electrospun polycaprolactone–chitosan nanofiber scaffolds. Int J Nanomedicine. 2014;9:995–1003.
   PubMed Web of Science ®Google Scholar
• Zhu W, Holmes B, Glazer RI, et al. 3D printed nanocomposite matrix for the study of breast cancer bone metastasis. Nanomed Nanotechnol Biol Med. 2016;12(1):69–79.
   PubMed Web of Science ®Google Scholar
• Akinoglu E, Ozbilgin K, Sonmez PK, et al. Biocompatibility of vertically aligned multi-walled carbon nanotube scaffolds for human breast cancer cell line MDA-MB-231. Prog Biomater. 2017;6(4):189–196.
   PubMed Web of Science ®Google Scholar
• Guiro K, Patel SA, Greco SJ, et al. Investigating breast cancer cell behavior using tissue engineering scaffolds. PLoS One. 2015;10(4):e0118724.
   PubMed Web of Science ®Google Scholar
• Vantangoli MM, Madnick SJ, Huse SM, et al. MCF-7 human breast cancer cells form differentiated microtissues in scaffold-free hydrogels. PLoS One. 2015;10(8):e0135426.
   PubMed Web of Science ®Google Scholar
• Abou-Elkacem L, Wilson KE, Johnson SM, et al. Ultrasound molecular imaging of the breast cancer neovasculature using engineered fibronectin scaffold ligands: a novel class of targeted contrast ultrasound agent. Theranostics. 2016;6(11):1740–1752.
   PubMed Web of Science ®Google Scholar
• Abberton K, Bortolotto S, Woods A, et al. Myogel, a novel, basement membrane-rich, extracellular matrix derived from skeletal muscle, is highly adipogenic in vivo and in vitro. Cells Tissues Organs. 2008;188(4):347–358.
   PubMed Web of Science ®Google Scholar
• Wang X, Reagan MR, Kaplan DL. Synthetic adipose tissue models for studying mammary gland development and breast tissue engineering. J Mammary Gland Biol Neoplasia. 2010;15(3):365–376.
   PubMed Web of Science ®Google Scholar
• Bissell MJ, Rizki A, Mian IS. Tissue architecture: the ultimate regulator of breast epithelial function. Curr Opin Cell Biol. 2003;15(6):753–762.
   PubMed Web of Science ®Google Scholar
• Oskarsson T. Extracellular matrix components in breast cancer progression and metastasis. Breast. 2013;22:S66–S72.
   PubMed Web of Science ®Google Scholar
• Egeblad M, Rasch MG, Weaver VM. Dynamic interplay between the collagen scaffold and tumor evolution. Curr Opin Cell Biol. 2010;22(5):697–706.
   PubMed Web of Science ®Google Scholar
• Tse JM, Cheng G, Tyrrell JA, et al. Mechanical compression drives cancer cells toward invasive phenotype. Proc Natl Acad Sci U S A. 2012;109(3):911–916.
   PubMed Web of Science ®Google Scholar
• Gudjonsson T, Rønnov-Jessen L, Villadsen R, et al. Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition. J Cell Sci. 2002;115(Pt 1):39–50.
   PubMed Web of Science ®Google Scholar
• Karousou E, D'Angelo ML, Kouvidi K, et al. Collagen VI and hyaluronan: the common role in breast cancer. BioMed Res Int. 2014;2014:1–10.
   Web of Science ®Google Scholar
• Kischel P, Waltregny D, Dumont B, et al. Versican overexpression in human breast cancer lesions: known and new isoforms for stromal tumor targeting. Int J Cancer. 2010;126(3):640–650.
   PubMed Web of Science ®Google Scholar
• Ricciardelli C, Brooks JH, Suwiwat S, et al. Regulation of stromal versican expression by breast cancer cells and importance to relapse-free survival in patients with node-negative primary breast cancer. Clin Cancer Res. 2002;8(4):1054–1060.
   PubMed Web of Science ®Google Scholar
• Oda G, Sato T, Ishikawa T, et al. Significance of stromal decorin expression during the progression of breast cancer. Oncol Rep. 2012;28(6):2003–2008.
   PubMed Web of Science ®Google Scholar
• Eshchenko TY, Rykova V, Chernakov A, et al. Expression of different proteoglycans in human breast tumors. Biochemistry (Moscow). 2007;72(9):1016–1020.
   PubMed Web of Science ®Google Scholar
• Neill T, Schaefer L, Iozzo RV. Decorin: a guardian from the matrix. Am J Pathol. 2012;181(2):380–387.
   PubMed Web of Science ®Google Scholar
• Troup S, Njue C, Kliewer EV, et al. Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer. Clin Cancer Res. 2003;9(1):207–214.
   PubMed Web of Science ®Google Scholar
• Sharma B, Ramus MD, Kirkwood CT, et al. Lumican exhibits anti-angiogenic activity in a context specific manner. Cancer Microenviron. 2013;6(3):263–271.
   PubMedGoogle Scholar
• Matsuda K, Maruyama H, Guo F, et al. Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells. Cancer Res. 2001;61(14):5562–5569.
   PubMed Web of Science ®Google Scholar
• Ioachim E, Charchanti A, Briasoulis E, et al. Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression. Eur J Cancer. 2002;38(18):2362–2370.
   PubMed Web of Science ®Google Scholar
• Oskarsson T, Acharyya S, Zhang XH, et al. Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nat Med. 2011;17(7):867–874.
   PubMed Web of Science ®Google Scholar
• Puglisi F, Puppin C, Pegolo E, et al. Expression of periostin in human breast cancer. J Clin Pathol. 2008;61(4):494–498.
   PubMed Web of Science ®Google Scholar
• Witkiewicz AK, Freydin B, Chervoneva I, et al. Stromal CD10 and SPARC expression in ductal carcinoma in situ (DCIS) patients predicts disease recurrence. Cancer Biol Ther. 2010;10(4):391–396.
   PubMed Web of Science ®Google Scholar
• Hsiao YH, Lien HC, Hwa HL, et al. SPARC (osteonectin) in breast tumors of different histologic types and its role in the outcome of invasive ductal carcinoma. Breast J. 2010;16(3):305–308.
   PubMed Web of Science ®Google Scholar
• Yee KO, Connolly CM, Duquette M, et al. The effect of thrombospondin-1 on breast cancer metastasis. Breast Cancer Res Treat. 2009;114(1):85–96.
   PubMed Web of Science ®Google Scholar
• Woodward TL, Lu H, Haslam SZ. Laminin inhibits estrogen action in human breast cancer cells. Endocrinology. 2000;141(8):2814–2821.
   PubMed Web of Science ®Google Scholar
• Mårlind J, Kaspar M, Trachsel E, et al. Antibody-mediated delivery of interleukin-2 to the stroma of breast cancer strongly enhances the potency of chemotherapy. Clin Cancer Res. 2008;14(20):6515–6524.
   PubMed Web of Science ®Google Scholar
• Kim Y, Ko H, Kwon IK, et al. Extracellular matrix revisited: roles in tissue engineering. Int Neurourol J. 2016;20(Suppl. 1):S23–S29.
   PubMed Web of Science ®Google Scholar
• Subia B, Dey T, Sharma S, et al. Target specific delivery of anticancer drug in silk fibroin based 3D distribution model of bone-breast cancer cells. ACS Appl Mater Interfaces. 2015;7(4):2269–2279.
   PubMed Web of Science ®Google Scholar
• Wang H, Yang Z. Short-peptide-based molecular hydrogels: novel gelation strategies and applications for tissue engineering and drug delivery. Nanoscale. 2012;4(17):5259–5267.
   PubMed Web of Science ®Google Scholar
• Mahmoodi M, Hossainalipour SM, Naimi-Jamal MR, et al. Influence of RGD grafting on biocompatibility of oxidized cellulose scaffold. Artif Cells Nanomed Biotechnol. 2013;41(6):421–427.
   PubMed Web of Science ®Google Scholar
• Retsky MW, Demicheli R, Hrushesky W, et al. Dormancy and surgery‐driven escape from dormancy help explain some clinical features of breast cancer. APMIS. 2008;116(7–8):730–741.
   PubMed Web of Science ®Google Scholar
• Iwatsuki M, Mimori K, Yokobori T, et al. Epithelial–mesenchymal transition in cancer development and its clinical significance. Cancer Sci. 2010;101(2):293–299.
   PubMed Web of Science ®Google Scholar
• Hollier BG, Evans K, Mani SA. The epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapies. J Mammary Gland Biol Neoplasia. 2009;14(1):29–43.
   PubMed Web of Science ®Google Scholar
• Patel SA, Ramkissoon SH, Bryan M, et al. Delineation of breast cancer cell hierarchy identifies the subset responsible for dormancy. Sci Rep. 2012;2(1):906.
   PubMed Web of Science ®Google Scholar
• Hutmacher DW, Loessner D, Rizzi S, et al. Can tissue engineering concepts advance tumor biology research? Trends Biotechnol. 2010;28(3):125–133.
   PubMed Web of Science ®Google Scholar
• Li X, Lewis MT, Huang J, et al. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst. 2008;100(9):672–679.
   PubMedGoogle Scholar
• Marlow R, Honeth G, Lombardi S, et al. A novel model of dormancy for bone metastatic breast cancer cells. Cancer Res. 2013;73(23):6886–6899.
   PubMed Web of Science ®Google Scholar
• Ghajar CM, Peinado H, Mori H, et al. The perivascular niche regulates breast tumour dormancy. Nat Cell Biol. 2013;15(7):807–817.
   PubMed Web of Science ®Google Scholar
• Cui H, Esworthy T, Zhou X, et al. Engineering a novel 3D printed vascularized tissue model for investigating breast cancer metastasis to bone. Adv Healthcare Mater. 2019;9:e1900924.
   Web of Science ®Google Scholar
• Mobini S, Khanmohammadi M, Heidari-Vala H, et al. Tissue engineering and regenerative medicine in Iran: current state of research and future outlook. Mol Biotechnol. 2015;57(7):589–605.
   PubMed Web of Science ®Google Scholar
• Nafisi N, Akbari ME, Mahjoub F, et al. Application of human acellular breast dermal matrix (ABDM) in implant-based breast reconstruction: an experimental study. Aesth Plast Surg. 2017;41(6):1435–1444.
   PubMed Web of Science ®Google Scholar
• Mahmoudzadeh A, Mohammadpour H. Tumor cell culture on collagen–chitosan scaffolds as three-dimensional tumor model: a suitable model for tumor studies. J Food Drug Anal. 2016;24(3):620–626.
   PubMed Web of Science ®Google Scholar
• Maroufi NF, Vahedian V, Mazrakhondi SAM, et al. Sensitization of MDA-MBA231 breast cancer cell to docetaxel by myricetin loaded into biocompatible lipid nanoparticles via sub-G1 cell cycle arrest mechanism. Naunyn-Schmiedeberg's Arch Pharmacol. 2020;393(1):1–11.
   Google Scholar
• Razmkhah M, Jaberipour M, Hosseini A, et al. Expression profile of IL-8 and growth factors in breast cancer cells and adipose-derived stem cells (ASCs) isolated from breast carcinoma. Cell Immunol. 2010;265(1):80–85.
   PubMed Web of Science ®Google Scholar